Table 6.
Univariate Kaplan–Meier analysis of disease-free survival
| Variable | Five-year overall survival | P-value |
|---|---|---|
| Age | 0.090 | |
| 60–69 years | 49 | |
| ≥70 years | 45 | |
| Gender | 0.210 | |
| Male | 51 | |
| Female | 46 | |
| Charlson comorbidity index | 0.089 | |
| ≤2 | 52 | |
| >2 | 44 | |
| ASA score | 0.181 | |
| I–II | 51 | |
| III | 45 | |
| Preoperative CEA level | 0.021 | |
| <5 ng/mL | 58 | |
| ≥5 ng/mL | 41 | |
| TNM stage of colorectal cancer | 0.032 | |
| I–II | 54 | |
| III | 46 | |
| Disease-free interval | 0.008 | |
| <12 months | 39 | |
| ≥12 months | 59 | |
| Tumor number | 0.128 | |
| <3 | 51 | |
| ≥3 | 44 | |
| Tumor laterality | 0.224 | |
| Left | 52 | |
| Right | 44 |
Abbreviations: ASA, American Society of Anesthesiologists; CEA, carcinoembryonic antigen; TNM, tumor-node-metastasis.